Moderna
MRNA
#392
Rank
โ‚น6.044 T
Marketcap
โ‚น15,139
Share price
8.55%
Change (1 day)
586.53%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: โ‚น6.044 Trillion

As of September 2026 Moderna has a market cap of โ‚น6.044 Trillion. This makes Moderna the world's 392th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น6.044 T452.29%
2025โ‚น1.094 T-17.39%
2024โ‚น1.324 T-58.03%
2023โ‚น3.156 T-44.72%
2022โ‚น5.710 T-25.5%
2021โ‚น7.664 T153.51%
2020โ‚น3.023 T544.07%
2019โ‚น469.41 B33.71%
2018โ‚น351.06 B

End of Day market cap according to different sources

On Sep 17th, 2026 the market cap of Moderna was reported to be:

โ‚น6.044 Trillion
by Nasdaq info icon info icon
โ‚น6.044 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น62.368 T 931.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น25.653 T 324.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น34.770 T 475.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
โ‚น54.10 B-99.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚น285.18 B-95.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚น79.8 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น3.146 T-47.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚น916.43 B-84.84%๐Ÿ‡บ๐Ÿ‡ธ USA